Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

Chronic lymphocytic leukemia has been studied using multiple levels of omics data. Here, the authors use exome sequencing, SNP, protein and gene expression data to identify distinct biologic tumor subtypes with heterogeneous prognostic impact after chemo- or immunochemotherapy.

Guardado en:
Detalles Bibliográficos
Autores principales: Johannes Bloehdorn, Andrejs Braun, Amaro Taylor-Weiner, Billy Michael Chelliah Jebaraj, Sandra Robrecht, Julia Krzykalla, Heng Pan, Adam Giza, Gulnara Akylzhanova, Karlheinz Holzmann, Annika Scheffold, Harvey E. Johnston, Ru-Fang Yeh, Tetyana Klymenko, Eugen Tausch, Barbara Eichhorst, Lars Bullinger, Kirsten Fischer, Martin Weisser, Tadeusz Robak, Christof Schneider, John Gribben, Lekh N. Dahal, Mathew J. Carter, Olivier Elemento, Dan A. Landau, Donna S. Neuberg, Mark S. Cragg, Axel Benner, Michael Hallek, Catherine J. Wu, Hartmut Döhner, Stephan Stilgenbauer, Daniel Mertens
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/fc98052a777c445bb5de9e2a3b17c607
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fc98052a777c445bb5de9e2a3b17c607
record_format dspace
spelling oai:doaj.org-article:fc98052a777c445bb5de9e2a3b17c6072021-12-02T18:33:47ZMulti-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia10.1038/s41467-021-25403-y2041-1723https://doaj.org/article/fc98052a777c445bb5de9e2a3b17c6072021-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-25403-yhttps://doaj.org/toc/2041-1723Chronic lymphocytic leukemia has been studied using multiple levels of omics data. Here, the authors use exome sequencing, SNP, protein and gene expression data to identify distinct biologic tumor subtypes with heterogeneous prognostic impact after chemo- or immunochemotherapy.Johannes BloehdornAndrejs BraunAmaro Taylor-WeinerBilly Michael Chelliah JebarajSandra RobrechtJulia KrzykallaHeng PanAdam GizaGulnara AkylzhanovaKarlheinz HolzmannAnnika ScheffoldHarvey E. JohnstonRu-Fang YehTetyana KlymenkoEugen TauschBarbara EichhorstLars BullingerKirsten FischerMartin WeisserTadeusz RobakChristof SchneiderJohn GribbenLekh N. DahalMathew J. CarterOlivier ElementoDan A. LandauDonna S. NeubergMark S. CraggAxel BennerMichael HallekCatherine J. WuHartmut DöhnerStephan StilgenbauerDaniel MertensNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Johannes Bloehdorn
Andrejs Braun
Amaro Taylor-Weiner
Billy Michael Chelliah Jebaraj
Sandra Robrecht
Julia Krzykalla
Heng Pan
Adam Giza
Gulnara Akylzhanova
Karlheinz Holzmann
Annika Scheffold
Harvey E. Johnston
Ru-Fang Yeh
Tetyana Klymenko
Eugen Tausch
Barbara Eichhorst
Lars Bullinger
Kirsten Fischer
Martin Weisser
Tadeusz Robak
Christof Schneider
John Gribben
Lekh N. Dahal
Mathew J. Carter
Olivier Elemento
Dan A. Landau
Donna S. Neuberg
Mark S. Cragg
Axel Benner
Michael Hallek
Catherine J. Wu
Hartmut Döhner
Stephan Stilgenbauer
Daniel Mertens
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
description Chronic lymphocytic leukemia has been studied using multiple levels of omics data. Here, the authors use exome sequencing, SNP, protein and gene expression data to identify distinct biologic tumor subtypes with heterogeneous prognostic impact after chemo- or immunochemotherapy.
format article
author Johannes Bloehdorn
Andrejs Braun
Amaro Taylor-Weiner
Billy Michael Chelliah Jebaraj
Sandra Robrecht
Julia Krzykalla
Heng Pan
Adam Giza
Gulnara Akylzhanova
Karlheinz Holzmann
Annika Scheffold
Harvey E. Johnston
Ru-Fang Yeh
Tetyana Klymenko
Eugen Tausch
Barbara Eichhorst
Lars Bullinger
Kirsten Fischer
Martin Weisser
Tadeusz Robak
Christof Schneider
John Gribben
Lekh N. Dahal
Mathew J. Carter
Olivier Elemento
Dan A. Landau
Donna S. Neuberg
Mark S. Cragg
Axel Benner
Michael Hallek
Catherine J. Wu
Hartmut Döhner
Stephan Stilgenbauer
Daniel Mertens
author_facet Johannes Bloehdorn
Andrejs Braun
Amaro Taylor-Weiner
Billy Michael Chelliah Jebaraj
Sandra Robrecht
Julia Krzykalla
Heng Pan
Adam Giza
Gulnara Akylzhanova
Karlheinz Holzmann
Annika Scheffold
Harvey E. Johnston
Ru-Fang Yeh
Tetyana Klymenko
Eugen Tausch
Barbara Eichhorst
Lars Bullinger
Kirsten Fischer
Martin Weisser
Tadeusz Robak
Christof Schneider
John Gribben
Lekh N. Dahal
Mathew J. Carter
Olivier Elemento
Dan A. Landau
Donna S. Neuberg
Mark S. Cragg
Axel Benner
Michael Hallek
Catherine J. Wu
Hartmut Döhner
Stephan Stilgenbauer
Daniel Mertens
author_sort Johannes Bloehdorn
title Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
title_short Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
title_full Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
title_fullStr Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
title_full_unstemmed Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
title_sort multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fc98052a777c445bb5de9e2a3b17c607
work_keys_str_mv AT johannesbloehdorn multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT andrejsbraun multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT amarotaylorweiner multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT billymichaelchelliahjebaraj multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT sandrarobrecht multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT juliakrzykalla multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT hengpan multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT adamgiza multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT gulnaraakylzhanova multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT karlheinzholzmann multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT annikascheffold multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT harveyejohnston multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT rufangyeh multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT tetyanaklymenko multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT eugentausch multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT barbaraeichhorst multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT larsbullinger multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT kirstenfischer multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT martinweisser multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT tadeuszrobak multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT christofschneider multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT johngribben multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT lekhndahal multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT mathewjcarter multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT olivierelemento multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT danalandau multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT donnasneuberg multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT markscragg multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT axelbenner multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT michaelhallek multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT catherinejwu multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT hartmutdohner multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT stephanstilgenbauer multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
AT danielmertens multiplatformprofilingcharacterizesmolecularsubgroupsandresistancenetworksinchroniclymphocyticleukemia
_version_ 1718377957480726528